IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q4 2016 Holdings

Filed 2017-02-13 | 16 holdings | $14.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Conmed Corp(CNMD)COM207410101$14.5M328,67798.2%
United Therapeutics Corp(UTHR)COM91307C102$38.9K270,9090.3%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$35.4K1,055,7190.2%
Gilead Sciences Inc(GILD)COM375558103$30.1K420,0000.2%
Sucampo PharmaceuticalsCOM864909106$25.3K1,863,7550.2%
Orthofix International NVCOMN6748L102$23.4K645,5300.2%
Halyard Health IncCOM40650V100$20.9K564,7920.1%
Amgen Inc(AMGN)COM031162100$18.6K127,1570.1%
Indivior PLCCOMG4766E108$17.0K4,650,4160.1%
Merck & Co. Inc.(MRK)COM58933Y105$14.9K252,8740.1%
Invacare CorpCOM461203101$14.4K1,102,5860.1%
RTI Surgical IncCOM74975N105$13.7K4,216,9480.1%
Derma Sciences IncCOM249827502$4.6K891,0260.0%
Aviragen Therapeutics IncCOM053761102$3.4K2,737,6020.0%
Digirad CorpCOM253827109$2.4K486,4000.0%
Juniper Pharmaceuticals IncCOM48203L107$1.6K290,8530.0%